Bring the product name into the appointment, not just the company name. Hims 3-in-1 Hard Mints means the 3-in-1 chew listing sildenafil, tadalafil and vitamin B12. The useful opening question is how that exact prescription would fit your symptoms, previous treatment and other medicines. This review turns the public offer into a set of notes you can take to the clinician.
Availability: Public product listing; individual eligibility and current prescription require confirmation.
The exact product
Start by asking the prescriber to read back the active ingredients and dosage form. Here the decision involves two ED drugs plus a vitamin, rather than three ED drugs. A familiar brand can offer several unrelated preparations; an account preference is not the prescription itself. Put the proposed medicine beside anything you already take, including intermittent treatments and supplements. If the names do not match what you expected, settle that discrepancy before interpreting a delivery or price promise.
| Provider | Hims |
|---|---|
| Listed active ingredients | Sildenafil + tadalafil + vitamin B12 |
| Dosage form | Compounded mint-flavored chew |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Hims: current ED treatment catalog · Hims: Hard Mints formulation safety library · Hims: Hard Mints chewable ED medicines |
Price, supply and payment
Make two entries in your notes: the advertised figure and the amount that would actually leave your account. The public figure for Hims 3-in-1 Hard Mints is From $30/month in the ED catalog. The table below keeps any verified supply details beside it. A starting price, unit price and monthly equivalent are different kinds of information. Ask about shipping, consultation charges, renewal and what happens to an unused supply if the clinician changes the treatment early.
| Current catalog headline | From $30/month |
|---|---|
| Separate chewable-page offer | Selected sildenafil/tadalafil mints from $6/use |
| Price limitation | The two headlines do not establish a five-chew plan |
| Name limitation | Other Hard Mints formulations have different active ingredients |
What the research can support
One practical way to read research is to name what was tested. The relevant record here is ingredient and regimen research; Hims user surveys are not trials of this exact chew. The unresolved question is the matching quantity, strengths and upfront payment. Those distinctions belong in the consultation because a study of an ingredient cannot silently become a promise about this package. Ask what alternatives the prescriber considered and which result would count as a useful improvement for your circumstances.
| Evidence boundary | ingredient and regimen research; Hims user surveys are not trials of this exact chew |
|---|---|
| Not established here | the matching quantity, strengths and upfront payment |
| Clinical and regulatory references | Cui et al. (2015): daily tadalafil with as-needed sildenafil · DailyMed: Tadalafil prescribing information, including section 5.11 · FDA: Compounding and the FDA — questions and answers · MedlinePlus: Sildenafil · MedlinePlus: Tadalafil |
Safety questions for the prescriber
Give safety questions their own place on the page. Hims 3-in-1 Hard Mints should not be added to an existing ED medicine without the prescribing team's instructions. Disclose nitrates, recreational nitrites, riociguat and blood-pressure medicines, together with heart, kidney, liver and eye conditions. A checklist cannot approve a prescription; it helps prevent omissions during the conversation. The additional product-specific issue below deserves an explicit answer.
| Multiple PDE5 inhibitors | Standard tadalafil labeling advises against combining PDE5 inhibitors; individualized rationale and monitoring are needed. |
|---|---|
| Added nutrients | Review actual amounts and duplicate supplements; nutrient inclusion does not prove improved ED efficacy. |
Availability and the actual prescription
Before arranging your routine around this offer, confirm that it is available to you. The research record says: Public product listing; individual eligibility and current prescription require confirmation. An older listing or safety document is useful evidence about a formulation but does not establish that a new patient can order it. Ask whether the state, account history, pharmacy or clinical assessment changes the options, and keep the exact name used in the reply.
Refills, changes and cancellation
Decide how to contact the clinical team before the first refill becomes a billing question. Record whether the medicine helped the problem you described, whether you followed its instructions, and what side effects occurred. For Hims 3-in-1 Hard Mints, take this question to the next conversation: “Why does this prescription combine both PDE5 inhibitors, and what role does B12 serve?” A message about symptoms and a request to stop shipments are separate tasks. Keep the account confirmation as well as the clinician's treatment instructions.
| Next charge | The next order date is the charge/processing date; a first refill can be scheduled early. |
|---|---|
| Cancellation notice | At least 48 hours before the next order, according to support guidance. |
| Already processing | Ending a subscription does not cancel an order already processing or shipped. |
| Refund boundary | No refund guaranteed after pharmacy processing. |
| Policy sources | Hims Support: canceling a subscription · Hims Support: refund policy · Hims Support: when billing occurs |
Compare named products
Use the linked alternatives to compare one concrete feature at a time: active ingredients, dosage form, schedule or full payment. Do not choose the longest ingredient list or the smallest milligram number as a shortcut. If an earlier treatment disappointed you, describe what happened rather than requesting a stronger-sounding brand. A comparison is useful when it improves the question you ask, not when it substitutes for an assessment.
Questions to keep with the offer
Your appointment note can end with three blanks: the exact prescription, the total first payment, and the date or trigger for clinical follow-up. Leave an item unanswered when the public evidence does not settle it. That is more useful than copying a competitor's terms into the gaps. This is documentary research; we have not ordered Hims 3-in-1 Hard Mints, tested its effects or evaluated the clinicians involved.
| Ask about this formula | Why does this prescription combine both PDE5 inhibitors, and what role does B12 serve? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Back to all individual product reviews
Sources for this page
Checked October 7, 2026. Company pages support descriptions of advertised offers, not independent claims of clinical quality.
- Hims: current ED treatment catalogProvider catalog; individual named offers and starting prices
- Hims: Hard Mints formulation safety libraryProvider formulation document; includes options not confirmed in the main catalog
- Hims Support: canceling a subscriptionProvider policy; 48-hour notice and orders already processing
- Hims Support: refund policyProvider policy; no guaranteed refund after pharmacy processing
- Hims Support: when billing occursProvider policy; next order date, charge timing, and subscription intervals
- Hims Support: changing the next order dateProvider support; refill rescheduling differs from cancellation
- Cui et al. (2015): daily tadalafil with as-needed sildenafilPrimary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI
- Hims: Hard Mints chewable ED medicinesProvider source; compounded formulations and advertised starting prices
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- MedlinePlus: SildenafilDrug information; standard sildenafil products
- MedlinePlus: TadalafilDrug information; standard tadalafil products